Methamphetamine-induced Fos expression in the substantia nigra pars reticulata in rats with a unilateral 6-OHDA lesion of the nigrostriatal fibers

Neuroscience Research

Volumn 30, Issue 4, 1998, Pages 355-360

  Ishida, Yasushi ^a   Todaka, Kazunari ^a   Kuwahara, Itsumi ^a   Nakane, Hideyuki ^a   Ishizuka, Yuta ^a   Nishimori, Toshikazu ^a   Mitsuyama, Yoshio ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

6 hydroxydopamine; Fos; Methamphetamine; Rat; Striatum; Substantia nigra pars reticulata

Indexed keywords

DIZOCILPINE; GLUTAMIC ACID; METHAMPHETAMINE; OXIDOPAMINE; PROTEIN C FOS;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; HEMISPHERE; IMMUNOREACTIVITY; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA;

ANIMALS; DIZOCILPINE MALEATE; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; METHAMPHETAMINE; NERVE FIBERS; OXIDOPAMINE; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, WISTAR; SUBSTANTIA NIGRA; SYMPATHOLYTICS; SYMPATHOMIMETICS; TYROSINE 3-MONOOXYGENASE;

EID: 0032052270     PISSN: 01680102     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-0102(98)00015-7     Document Type: Article

References (22)

1. Berretta S., Robertson H.A., Graybiel A.M. Dopamine and glutamate agonistsstimulate neuron-specific expression of Fos-like protein in the striatum. J. Neurophysiol. 68:1992;767-777.
2. Bjelke B., Strömberg I., O'Connor W.T., Andbjer B., Agnati L.F., Fuxe K. Evidence for volume transmission in the dopamine denervated neostriatum of the rat after a unilateral nigral 6-OHDA microinjection. Studies with systemic D-amphetamine treatment. Brain Res. 662:1994;11-24.
3. Cenci M.A., Kalén P., Mandel R.J., Wictorin K., Björklund A. Dopaminergic transplants normalize amphetamine- and apomorphine-induced Fos expression in the 6-hydroxydopamine-lesioned striatum. Neuroscience. 46:1992;943-957.
4. 1-mediated turning behavior and striatal c-fos expression by the substantia nigra. Synapse. 19:1995;233-240.
5. Graybiel A.M., Moratalla R., Robertson H.A. Amphetamine and cocaine induce drug-specific activation of the c-fos gene in striosome-matrix compartments and limbic subdivisions of the striatum. Proc. Natl. Acad. Sci. USA. 87:1990;6912-6916.
6. Hatanaka H., Arimatsu Y. Monoclonal antibodies to tyrosine hydroxylase from rat pheochromocytoma PC12h cells with special reference to nerve growth factor-mediated increase of the immunoprecipitable enzymes. Neurosci. Res. 1:1984;253-263.
7. Ishida Y., Hashiguchi H., Todaka K., Kuwahara I., Mitsuyama Y. Dopaminergic transplants alter in vivo activity of tryptophan hydroxylase in the striatum in a rat model of Parkinson's disease. Neurosci. Lett. 210:1996;75-78.
8. Ishida Y., Kuwahara I., Todaka K., Hashiguchi H., Nishimori T., Mitsuyama Y. Dopaminergic transplants suppress L-DOPA-induced Fos expression in the dopamine-depleted striatum in a rat model of Parkinson's disease. Brain Res. 727:1996;205-211.
9. König, J.F.R., Klippel, R.A., 1963. The Rat Brain. A Stereotaxic Atlas of the Forebrain and Lower Parts of the Brain Stem, Williams and Wilkins, Baltimore.
10. Morgan J.I., Curran T. Stimulus-transcription coupling in the nervous system: involvement of the inducible proto-oncogenes fos and jun. Annu. Rev. Neurosci. 14:1991;421-451.
11. Nishino H., Hashitani T., Kumazaki M., Sato H., Furuyama F., Isobe Y., Watari N., Kanai M., Shiosaka S. Long-term survival of grafted cells, dopamine synthesis/release, synaptic connections, and functional recovery after transplantation of fetal nigral cells in rats with unilateral 6-OHDA lesions in the nigrostriatal dopamine pathway. Brain Res. 534:1990;83-93.
12. Ohno M., Yoshida H., Watanabe S. NMDA receptor-mediated expression of Fos protein in the rat striatum following methamphetamine administration: relation to behavioral sensitization. Brain Res. 665:1994;135-140.
13. Paul M.L., Graybiel A.M., David J.-C., Robertson H.A. D1-like and D2-like dopamine receptors synergistically activate rotation and c-fos expression in the dopamine-depleted striatum in a rat model of Parkinson's disease. J. Neurosci. 12:1992;3729-3742.
14. 2 dopamine receptors differentially regulate c-fos expression in striatonigral and striatopallidal neurons. Neuroscience. 49:1992;285-296.
15. 1-dopamine receptor agonists selectively activate striatal c-fos independent of rotational behaviour. Brain Res. 503:1989;346-349.
16. Schmidt R.H., Björklund A., Stenevi U., Dunnett S.B., Gage F.H. Intracerebral grafting of neuronal cell suspensions. III. Activity of intrastriatal nigral suspension implants as assessed by measurements of dopamine synthesis and metabolism. Acta Physiol. Scand. Suppl. 522:1983;19-28.
17. Sheng M., Greenberg M.E. The regulation and function of c-fos and other immediate early genes in the nervous system. Neuron. 4:1990;477-485.
18. Snyder-Keller A.M. Striatal c-fos induction by drugs and stress in neonatally dopamine-depleted rats given nigral transplants: importance of NMDA activation and relevance to sensitization phenomena. Exp. Neurol. 113:1991;155-165.
19. 2 dopamine agonists differentially alter basal ganglia glucose utilization in rats with unilateral 6-hydroxydopamine substantia nigra lesions. J. Neurosci. 7:1987;2927-2935.
20. Umino A., Nishikawa T., Takahashi K. Methamphetamine-induced nuclear c-fos in rat brain regions. Neurochem. Int. 26:1995;85-90.
21. Wüllner U., Testa C.M., Catania M.V., Young A.B., Penney J.B. Glutamate receptors in striatum and substantia nigra: Effects of medial forebrain bundle lesions. Brain Res. 645:1994;98-102.
22. 2 dopamine receptors in the basal ganglia of the rat: light and electron microscopy. Neuroscience. 65:1995;709-730.